CIRSE Registry for LifePearl Microspheres
Launched by CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGICAL SOCIETY OF EUROPE · Mar 15, 2017
Trial Information
Current as of May 17, 2025
Completed
Keywords
ClinConnect Summary
CIREL will capture a broad spectrum of real clinical data on the delivery of transcatheter arterial chemoembolisation (TACE) using LifePearl Microspheres loaded with Irinotecan (LP-IRI) and the observed clinical outcomes. The aim of doing so is to improve our understanding of how LifePearl microspheres are administered as part of the standard treatment of colorectal adenocarcinoma with liver metastases in Europe. Ultimately, the collection of real-life data is intended to provide an evidence-base from which conclusions can be drawn on how to optimise treatment protocols and consequently the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with liver-only or liver-dominant metastatic disease in patients with colorectal adenocarcinoma
- • treatment with LifePearl Microspheres
- • signed informed consent form
- • 18 years or older
- Exclusion Criteria:
- • withdrawal of informed consent
About Cardiovascular And Interventional Radiological Society Of Europe
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) is a leading professional organization dedicated to advancing the field of interventional radiology and cardiovascular medicine. With a commitment to enhancing patient care through research, education, and collaborative practices, CIRSE fosters innovation and knowledge exchange among healthcare professionals across Europe and beyond. By sponsoring clinical trials and promoting evidence-based practices, CIRSE plays a pivotal role in shaping the future of interventional techniques and improving clinical outcomes in cardiovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Philippe Pereira, Prof.
Study Chair
Interventional Radiologist at SLK Klinikum Heilbronn GmbH, Germany
Julien Taieb, Prof.
Study Chair
Oncologist at Georges Pompidou European Hospital, Paris, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials